Oral anticoagulation therapy in children: Successfully controlled by self-management

Heart Surgery Forum

Volumn 7, Issue 4, 2004, Pages 221-225

  Christensen, Thomas Decker ^a,b   Andersen, Niels Trolle ^a,b   Maegaard, Marianne ^a,b   Hansen, Ole Kromann ^a,b   Hjortdal, Vibeke Elisabeth ^a,b   Hasenkam, Michael ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; COUMARIN; PHENPROCOUMON; WARFARIN; COUMARIN DERIVATIVE;

ADOLESCENT; ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BLOOD ANALYSIS; CARDIOPULMONARY HEMODYNAMICS; CHILD; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONGENITAL HEART DISEASE; CONSULTATION; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEATH; DRUG INDICATION; DRUG SAFETY; EXPERIENCE; HEALTH CARE QUALITY; HEART SURGERY; HEART VALVE PROSTHESIS; HOSPITALIZATION; HUMAN; INJECTION PAIN; INTERNATIONAL STANDARD UNIT; MEDICAL ASSESSMENT; PATIENT MONITORING; PHYSICAL CAPACITY; PRIORITY JOURNAL; SELF CARE; THROMBOEMBOLISM; VEIN PUNCTURE; CLINICAL TRIAL; CONGENITAL HEART MALFORMATION; DRUG SELF ADMINISTRATION; FEMALE; INFANT; MALE; METHODOLOGY; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRESCHOOL CHILD; THROMBOSIS; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADOLESCENT; ANTICOAGULANTS; CHILD; CHILD, PRESCHOOL; COUMARINS; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; MALE; PATIENT COMPLIANCE; SELF ADMINISTRATION; THROMBOSIS; TREATMENT OUTCOME;

EID: 4644265527     PISSN: 10983511     EISSN: None     Source Type: Journal    
DOI: 10.1532/HSF98.20041000     Document Type: Article

References (22)

1. Andrew M, Marzinotto V, Brooker LA, et al. 1994. Oral anticoagulation therapy in pediatric patients: a prospective study. Thromb Haemost 71:265-9.
2. Ansell JE, Hughes R. 1996. Evolving models of warfarin management: anticoagulation clinics, patient self-monitoring, and patient self-management. Am Heart J 132:1095-100.
3. Attermann J, Kynde K, Hasenkam JM. 1998. Precision of patients' measurements of the international normalized ratio (INR) using a patient operated whole blood home coagulometer. Thromb Res 92:287-91.
4. Buck ML. 1996. Anticoagulation with warfarin in infants and children. Ann Pharmacother 30:1316-22.
5. Cabalka AK, Emery RW, Petersen RJ, et al. 1995. Long-term follow-up of the St. Jude Medical prosthesis in pediatric patients. Ann Thorac Surg 60:S618-23.
6. Christensen TD, Attermann J, Hjortdal VE, Maegaard M, Hasenkam JM. 2001. Self-management of oral anticoagulation in children with congenital heart disease. Cardiol Young 11:269-76.
7. Cromheecke ME, Levi M, Colly LP, et al. 2000. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet 356:97-102.
8. Günther T, Mazzitelli D, Schreiber C, et al. 2000. Mitral-valve replacement in children under 6 years of age. Eur J Cardiothorac Surg 17:426-30.
9. Hasenkam JM, Kimose HH, Knudsen L, et al. 1997. Self management of oral anticoagulant therapy after heart valve replacement. Eur J Cardiothorac Surg 11:935-42.
10. Horstkotte D, Piper C, Schulte HD, Schultheiss HP. 1996. Improvement of prognosis by home prothrombin estimation in patients with life-long anticoagulant therapy [abstract]. Eur Heart J 17(suppl):230.
11. Körtke H, Körfer R. 2001. International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous? Ann Thorac Surg 72:44-8.
12. Marzinotto V, Monagle P, Chan A, et al. 2000. Capillary whole blood monitoring of oral anticoagulants in children in outpatient clinics and the home setting. Pediatr Cardiol 21:347-52.
13. Massicotte P, Marzinotto V, Vegh P, Adams M, Andrew M. 1995. Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitor. J Pediatr 127:389-94.
14. Michelson AD, Bovill E, Andrew M. 1995. Antithrombotic therapy in children. Chest 108:506S-22S.
15. Samsa GP, Matchar DB. 2000. Relationship between test frequency and outcomes of anticoagulation: a literature review and commentary with implications for the design of randomized trials of patient self-management. J Thromb Thrombolysis 9:283-92.
16. Spevak PJ, Freed MD, Castaneda AR, Norwood WI, Pollack P. 1986. Valve replacement in children less than 5 years of age. J Am Coll Cardiol 8:901-8.
17. Steffensen FH, Kristensen K, Ejlersen E, Dahlerup JF, Sørensen HT. 1997. Major haemorrhagic complications during oral anticoagulant therapy in a Danish population-based cohort. J Intern Med 242:497-503.
18. Stewart S, Cianciotta D, Alexson C, Manning J. 1987. The long-term risk of warfarin sodium therapy and the incidence of thromboembolism in children after prosthetic cardiac valve replacement. J Thorac Cardiovasc Surg 93:551-4.
19. Streif W, Andrew M, Marzinotto V, et al. 1999. Analysis of warfarin therapy in pediatric patients: a prospective cohort study of 319 patients. Blood 94:3007-14.
20. Van den Besselaar AM. 2001. Accuracy, precision, and quality control for point-of-care testing of oral anticoagulation. J Thromb Thrombolysis 12:35-40.
21. Van den Besselar AM. 2000. A comparison of INRs determined with a whole blood prothrombin time device and two international reference preparations for thromboplastin. Thromb Haemost 84:410-2.
22. Vosa C, Renzulli A, Lombardi PF, Damiani G. 1995. Mechanical valve replacement under 12 years of age: 15 years of experience. J Heart Valve Dis 4:279-83.